The global clinical reference laboratory market size was valued at $9,290.3 million in 2019 and is projected to reach $15,774.3 million by 2033, exhibiting a CAGR of 6.4% during the forecast period. The growth of this market is attributed to the surge in the number of diagnostic laboratories globally, rising adoption of automated testing solutions, and the emergence of specialized clinical reference laboratories.
The clinical reference laboratory market has witnessed a significant growth over the past few years and is expected to continue growing in the forecast period as well. This growth is attributed to increasing government support for the development of clinical laboratories and private investments in the R&D and development of new technologies for diagnosis. In addition, the rising prevalence of chronic and infectious diseases and the growing adoption of automation in the laboratory testing procedures are expected to continue driving the demand for reference laboratories.
Download Sample Copy of This Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=8520?PJ
Key Companies Profiled
- OPKO Health Inc.
- Quest Diagnostics Incorporated
- Myriad Genetics
- LabCorp
- NeoGenomics
- Unilabs
- Sonic HealthCare Limited
- KingMed Diagnostics
- SYNAB International GmbH
- ARUP Laboratories
Competitive Landscape
The competitive landscape of the Clinical Reference Laboratory market is expected to remain fairly competitive over the 2023 to 2033 forecast period. The market will likely see players expanding their geographic footprint into adjacent markets and different geographies by forming partnerships with local players and engaging in joint ventures. The large number of existing players along with the likely entry of new companies is expected to keep competition levels high.
Major players in the clinical reference laboratory market include Laboratory Corporation of America (LabCorp), Quest Diagnostics, OPKO Health, Charles River Laboratories, BioReference Laboratories, Inc, Sonic Healthcare, Cantel Medical, Compass Biomedical, Eurofins Scientific, Synevo Group, and IBT Laboratories.
Strategic players are likely to focus on mergers and acquisitions, collaborations, and make investments in research and development to create new products and services. Companies are also likely to develop stronger digital services to include access to remote consultations, portable diagnostic platforms, and self-reported data tools to enhance customer engagement and diagnose diseases at an early stage.
Clinical Reference Laboratory Industry Research Segmentation
- By Type :
- Standalone
- Clinical-based
- Hospital-based
- By Application :
- Clinical Trials
- Laboratory Medicine
- By Region :
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Get Customization on this Report for Specific Research Solutions:https://www.factmr.com/connectus/sample?flag=RC&rep_id=8520?PJ
Questionnaire answered in the Market outlook Report of Clinical reference laboratory market include:
- What is the key strategy deployed by large players to maximize Clinical reference laboratory market growth?
- What are the main challenges faced by players in the Clinical reference laboratory market Demand?
- With the advent of technological advancement, how will the Clinical reference laboratory market landscape change over the forecast period?
- What does player bring to the table which is unique as a strategy, and is easy to emulate for new investors in the Clinical reference laboratory market size?
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com
